Jubilant Ingrevia Intrinsic Value
Jubilant Ingrevia (JUBLINGREA) median intrinsic value is ₹1360.90 from 9 valuation models (range ₹204–₹1701), vs current price ₹680.45 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Browse JUBLINGREA complete financial statements for revenue, profit, balance sheet and cash flow data.
JUBLINGREA Valuation Methods Summary — DCF, Graham Number & P/E
Jubilant Ingrevia intrinsic value across 9 models vs current price ₹680.45 — upside/downside and value range per method. Also explore JUBLINGREA price trends to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹262.56 | ₹210.05 - ₹315.07 | -61.4% | EPS: ₹21.88, Sector P/E: 12x |
| Book Value Method | asset | ₹1701.12 | ₹1531.01 - ₹1871.23 | +150.0% | Book Value/Share: ₹1829.38, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1360.90 | ₹1224.81 - ₹1496.99 | +100.0% | Revenue/Share: ₹2937.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1360.90 | ₹1224.81 - ₹1496.99 | +100.0% | EBITDA: ₹636.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1701.12 | ₹1360.90 - ₹2041.34 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹204.14 | ₹183.73 - ₹224.55 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹204.14 | ₹183.73 - ₹224.55 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1360.90 | ₹1224.81 - ₹1496.99 | +100.0% | ROE: 11.8%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹949.00 | ₹854.10 - ₹1043.90 | +39.5% | EPS: ₹21.88, BVPS: ₹1829.38 |
JUBLINGREA Intrinsic Value vs Market Price — All Valuation Models
Jubilant Ingrevia fair value range ₹204–₹1701 vs current market price ₹680.45 across 9 valuation models. For current market price and key ratios, visit JUBLINGREA stock price BSE.
JUBLINGREA Intrinsic Value Analysis — Undervalued or Overvalued?
Jubilant Ingrevia median intrinsic value ₹1360.90, current price ₹680.45 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of JUBLINGREA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Jubilant Ingrevia (JUBLINGREA) is ₹1360.90 (median value). With the current market price of ₹680.45, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹204.14 to ₹1701.12, indicating ₹204.14 - ₹1701.12.
Is JUBLINGREA undervalued or overvalued?
Based on our multi-method analysis, Jubilant Ingrevia (JUBLINGREA) appears to be trading below calculated value by approximately 100.0%.
JUBLINGREA Financial Health — Key Ratios vs Industry Benchmarks
Jubilant Ingrevia financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.8% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.93x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
JUBLINGREA Cash Flow Quality — Operating & Free Cash Flow
Jubilant Ingrevia operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹508 Cr | ₹314 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹430 Cr | ₹146 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹463 Cr | ₹229 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹453 Cr | ₹418 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹112 Cr | ₹112 Cr | Positive Free Cash Flow | 8/10 |